Pomalidomide manufacturer
Pomalidomide is a potent immunomodulatory drug (IMiD) primarily used in the treatment of multiple myeloma, a cancer of the plasma cells in bone marrow. It belongs to a class of drugs known for their ability to modulate the immune system and inhibit cancer cell growth through various mechanisms, including anti-angiogenic and anti-inflammatory effects.